Growth hormone-releasing peptide 1

DB19259InvestigationalSmall molecule

Growth hormone-releasing peptide 1 is under investigation in clinical trial NCT00381602 (A Phase II, Randomized, Cross-over, Vehicle-controlled, Double-blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in...

Formula / weight: C₅₁H₆₂N₁₂O₇ · 955.134 g/mol (avg)
Also known as: Ala-his-3-(2-naphthalenyl)-d-ala-ala-trp-d-phe-lys-nh2 · L-alanyl-l-histidyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide
Code names: GHRP-1

Resolves to

Compound

UNII39EVI31P0WCAS141925-59-9ChEMBLCHEMBL427926

Structure

InChIKeyNWQWNCILOXTTHF-HLCSKTDOSA-NSMILES

C[C@H](N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC1=CC2=CC=CC=C2C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Growth hormone-releasing peptide 1, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account